Nitrosigine® Supplementation Effective in Reducing Inflammation Associated with Joint Health
NUTRITION 21 ANNOUNCES THE PRESENTATION OF A PRECLINICAL EVALUATION OF THE EFFECT OF NITROSIGINE® ON INFLAMMATORY MARKERS AND ARTHRITIS AT THE RENOWNED EXPERIMENTAL BIOLOGY 2017 ANNUAL MEETING
PURCHASE, NEW YORK – APRIL 25, 2017 – Nutrition 21, LLC (“Nutrition 21”) is proud to announce the presentation of new preclinical study results supporting Nitrosigine® bonded arginine silicate (ASI), titled, “Effect of Bonded Arginine Silicate on Inflammatory Markers and Arthritis.” The study was presented on April 23rd, 2017 to scientists and other professionals at the acclaimed Experimental Biology 2017 annual meeting and the abstract will be published in the Federation of American Societies for Experimental Biology Journal (FASEB).
Read the full press release here – Nitrosigine® Supplementation Effective in Reducing Inflammation Associated with Joint Health
To find out more about Nitrosigine, visit http://www.Nitrosigine.com